East Brunswick, NJ, United States of America

Reynalda Keh Dejesus

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2015-2019

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Reynalda Keh Dejesus: Innovator in Pharmaceutical Science

Introduction

Reynalda Keh Dejesus is a prominent inventor based in East Brunswick, NJ (US), known for her significant contributions to pharmaceutical science. With a total of five patents to her name, she has made remarkable advancements in the field of medicine, particularly in the development of compounds that address critical health issues.

Latest Patents

One of her latest patents is focused on inhibitors of the renal outer medullary potassium channel. This invention provides compounds that serve as diuretic and/or natriuretic agents, which can be used in the therapy and prophylaxis of various medical conditions, including cardiovascular diseases such as hypertension, heart failure, and chronic kidney disease. Another notable patent involves bicyclic aryl monobactam compounds, which are designed for the treatment of bacterial infections. This invention includes methods for administering these compounds effectively, either alone or in combination with beta-lactamase inhibitors.

Career Highlights

Reynalda Keh Dejesus is currently employed at Merck Sharp & Dohme Corporation, where she continues to innovate and contribute to the pharmaceutical industry. Her work has been instrumental in developing new therapeutic options that improve patient outcomes.

Collaborations

Throughout her career, Reynalda has collaborated with esteemed colleagues, including Haifeng Tang and Alexander Pasternak. These partnerships have fostered a collaborative environment that enhances the research and development of new medical solutions.

Conclusion

Reynalda Keh Dejesus exemplifies the spirit of innovation in the pharmaceutical field. Her patents and ongoing work at Merck Sharp & Dohme Corporation highlight her commitment to advancing medical science and improving health outcomes for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…